You are here

Article Text

Article menu

Download PDFPDF

Notification and correction
NOTIFICATION AND CORRECTION
View Full Text

http://dx.doi.org/10.1136/ard.2002.005371corr1

Statistics from Altmetric.com

    Does long term treatment with azathioprine predispose to malignancy and death in patients with systemic lupus erythematosus? (Nero P, Rahman A, Isenberg DA. Ann Rheum Dis 2004;63:325–6.)

    We regret that the references for this letter were omitted. They are given below.

    1

    Hazleman B. Incidence of neoplasms in patients with rheumatoid arthritis exposed to different treatment regimens. Am J Med1985;78(suppl 1A):39–43.
    OpenUrl

    2

    Moll JMH. Drug therapy (3): “specific” drugs. In: Management of rheumatic disorders. 1st ed. London: Chapman and Hall: 1983:169–212.

    3

    Silman A, Petrie J, Hazleman B, Evans S. Lymphoproliferative cancer and other malignancy in patients with rheumatoid arthritis treated with azathioprine: a 20-year follow up study. Ann Rheum Dis1988;47:988–92.
    OpenUrlAbstract/FREE Full Text

    4

    Sutcliffe N, Smith C, Speight PM, Isenberg DA. Mucosa-associated lymphoid tissue lymphomas in two patients with rheumatoid arthritis on second-line agents, and secondary Sjögren syndrome. Rheumatology (Oxford)2000;39:185–8.

    View Abstract

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Copyright information:

    Copyright 2004 by Annals of the Rheumatic Diseases

    Linked Articles